A number of studies have shown that the increase in counterregulatory hormone concentrations induced by hypoglycemia is reduced in insulin-dependent diabetics (IDD's) as compared to nondiabetic controls. In particular, the failure of plasma epinephrine levels to rise normally in IDD's occurs together with the impaired secretion of glucagon. This leads to loss of the acute hormonal response to insulin-induced hypoglycemia which, in turn, results in the lack of rebound in hepatic glucose output posthypoglycemia and delayed recovery to safe blood glucose concentrations. This proposal will study the mechanism underlying the loss of an adequate epinephrine response in IDD's and therapeutic implications of this. Specifically, studies are designed to evaluate the scope of the hormonal abnormality in Type I diabetes in humans by using multiple stimuli to assess secretory responses of epinephrine, glucagon, cortisol, growth hormone, and norepinephrine using non-hypoglycemic and hypoglycemic stimuli. Since preliminary evidence suggests that exercise may potentiate the catecholamine response to hypoglycemia in normal but not diabetic subjects, studies are proposed to explore the relative roles of epinephrine secretion or clearance and the severity of the exercise stimulus in this phenomenon. Experiments in which blood glucose will be held constant during exercise will determine whether the hormone responses to exercise are related to the glucose level, whether their response is still modulated by changes in glucose and whether the defect in epinephrine response is also present in non-insulin dependent diabetes. Finally, the role of epinephrine in exercise-induced glucose production will be evaluated. These studies may help to define the cause(s) of the observed hormonal deficits in IDDM and serve to clarify the role of exercise in the therapy of diabetes.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK036617-03
Application #
3235090
Study Section
Metabolism Study Section (MET)
Project Start
1986-06-01
Project End
1989-12-31
Budget Start
1988-06-01
Budget End
1989-12-31
Support Year
3
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Albert Einstein College of Medicine
Department
Type
Schools of Medicine
DUNS #
009095365
City
Bronx
State
NY
Country
United States
Zip Code
10461
Mellman, M J; Davis, M R; Brisman, M et al. (1994) Effect of antecedent hypoglycemia on cognitive function and on glycemic thresholds for counterregulatory hormone secretion in healthy humans. Diabetes Care 17:183-8
Davis, M R; Shamoon, H (1992) Impaired glucose disposal following mild hypoglycemia in nondiabetic and type I diabetic humans. Metabolism 41:216-23
Mellman, M J; Davis, M R; Shamoon, H (1992) Effect of physiological hyperinsulinemia on counterregulatory hormone responses during hypoglycemia in humans. J Clin Endocrinol Metab 75:1293-7
Tibaldi, J M; Lorber, D; Lomasky, S et al. (1992) Postprandial hypoglycemia in islet beta cell hyperplasia with adenomatosis of the pancreas. J Surg Oncol 50:53-7
Davis, M R; Mellman, M; Shamoon, H (1992) Further defects in counterregulatory responses induced by recurrent hypoglycemia in IDDM. Diabetes 41:1335-40
Davis, M R; Shamoon, H (1991) Deficient counterregulatory hormone responses during hypoglycemia in a patient with insulinoma. J Clin Endocrinol Metab 72:788-92
Davis, M R; Shamoon, H (1991) Counterregulatory adaptation to recurrent hypoglycemia in normal humans. J Clin Endocrinol Metab 73:995-1001
Amar, D; Shamoon, H; Frishman, W H et al. (1991) Effects of labetalol on perioperative stress markers and isoflurane requirements. Br J Anaesth 67:296-301
Shilo, S; Sotsky, M; Shamoon, H (1990) Islet hormonal regulation of glucose turnover during exercise in type 1 diabetes. J Clin Endocrinol Metab 70:162-72
Sotsky, M J; Shilo, S; Shamoon, H (1989) Regulation of counterregulatory hormone secretion in man during exercise and hypoglycemia. J Clin Endocrinol Metab 68:9-16